Jannemieke Ouwerkerk

Author

Also Known As

J OUWERKERK, J Ouwerkerk, J. Ouwerkerk, J.W. (Jannemieke) Ouwerkerk, J.W. Ouwerkerk, Jannemieke Ouwerkerk, Jannemieke W. Ouwerkerk, Ouwerkerk, Ouwerkerk J., Ouwerkerk, J.

Publications

676

Citations

H-Index

Concepts

All Affiliations

Leiden University Medical Center The Netherlands Cancer Institute Slotervaartziekenhuis Leiden University

About

Jannemieke Ouwerkerk is an author at Leiden University Medical Center specializing in medicine, pharmacotherapy, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	278
2	Public Health	2	2	130
3	Law	1	1	15
4	Emergency Medicine	1	1	12
5	Health Policy	1	1	12

Jannemieke Ouwerkerk

Publications

349

Citations

H-Index

Page 1

	Year	Citations
Risk factors for catheter-related thrombosis in cancer patients Margot Tesselaar, Jannemieke Ouwerkerk, M A Nooy, European Journal of Cancer ThrombosisPulmonary EmbolismVenous DiseaseVenous ThrombosisCardiovascular Disease	2004	118
Quantification of sunitinib in human plasma by high-performance liquid chromatography–tandem mass spectrometry☆ Patton Minkin, Ming Zhao, Z CHEN, Journal of Chromatography B Gas ChromatographyMedicineBioanalysisMass SpectrometryHuman Plasma	2008	69
Evaluation of the autoinduction of ifosfamide metabolism by a population pharmacokinetic approach using NONMEM Thomas Kerbusch, Alwin D. R. Huitema, Jannemieke Ouwerkerk, British Journal of Clinical Pharmacology	2000	46
Ifosfamide treatment as a 10-day continuous intravenous infusion H.J. Keizer, Jannemieke Ouwerkerk, K Welvaart, Journal of Cancer Research and Clinical Oncology ThrombosisTherapeutic ControversyPharmacotherapyMedicineAnticoagulant	1995	28
Effect of ifosfamide treatment on glutathione and glutathione conjugation activity in patients with advanced cancers. T. M. T. Mulders, Keizer, Jannemieke Ouwerkerk, PubMed Glutathione/glutathione S-transferaseChemoprevention StrategyCancer ManagementImmunologyPathology	1995	18
The European Protection Order: No Time to Waste or a Waste of Time? Jannemieke Ouwerkerk, Suzan van der Aa European Journal of Crime Criminal Law and Criminal Justice European Community LawPublic PolicyEuropean LawInternational RelationsSecurity	2011	15
Population pharmacokinetics and exploratory pharmacodynamics of ifosfamide and metabolites after a 72-h continuous infusion in patients with soft tissue sarcoma Thomas Kerbusch, R. Math x F t, Hiskias G. Keizer, European Journal of Clinical Pharmacology Soft Tissue SarcomaMedicinePharmacologyPharmacotherapy72-H Continuous Infusion	2001	13
Repeated automated versus daytime ambulatory blood pressure measurement in mild, moderate and severe untreated black hypertensive patients. UK Mueller, Mike Wells, I I Radevski, PubMed HypertensionBlood Pressure MeasurementsPressure MeasurementBlood Pressure VariabilityBlood Pressure	1997	12
Prophylaxis with low molecular weight heparin reduces the risk for catheter-related venous thrombosis in cancer patients with centrally but not peripherally inserted central venous catheters for administration of chemotherapy Margot Tesselaar, Jannemieke Ouwerkerk, Frits R. Rosendaal, European Journal of Cancer ThrombosisVenous ThrombosisMedicineAnticoagulantPharmacotherapy	2001	10
Distribution of ifosfamide and metabolites between plasma and erythrocytes Thomas Kerbusch, Virginie M.M. Herben, M-J. J. Jeuken, Biopharmaceutics & Drug Disposition ThrombopoiesisPharmacological StudyIfosforamide MustardMedicineBioanalysis	2001	10

Page 1